By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OLIGOMERIX 

Audubon Business and Technology Center
Columbia University Medical Center

3960 Broadway, Suite 440C
New York  New York  10032  U.S.A.
Phone: 212-568-0365 Fax: 212-568-0469


SEARCH JOBS



Segment
Start Up





Company News
OLIGOMERIX To Present Its Drug Discovery Program Targeting Tau Oligomers At The Federation Of European Neuroscience Societies Forum And The Alzheimer's Association International Conference® 6/30/2014 9:07:32 AM
OLIGOMERIX To Present At Biotech Showcase™ 2014 1/7/2014 8:41:47 AM
Taconic And OLIGOMERIX To Collaborate On Tau Mouse Model Characterization For Use In Alzheimer's Disease Research 12/9/2013 11:12:28 AM
OLIGOMERIX Awarded Phase IIB Grant From the NIH to Discover Drugs That Inhibit Alzheimer's Disease Progression 9/10/2013 10:50:16 AM
OLIGOMERIX Release: Identification of a Tau Oligomer Structure That is Toxic to Neurons Published in the International Journal of Cell Biology 9/4/2013 10:43:56 AM
OLIGOMERIX Announces Addition of Industry Veteran James Hendrix, Ph.D., to Serve as Senior Director of Chemistry 7/16/2013 10:05:23 AM
OLIGOMERIX to Present Multiple Posters Highlighting its Tau-Focused Technology During the Annual Alzheimer's Association International Conference® 7/9/2013 6:34:53 AM
OLIGOMERIX Completes Series B Financing 5/22/2013 10:22:49 AM
OLIGOMERIX Completes $2 Million Series A Financing 4/23/2012 10:25:33 AM
A New Mechanism for Tau Protein Pathology in Alzheimer's Disease was Presented by OLIGOMERIX at the Society For Neuroscience Annual Meeting 11/17/2011 11:43:47 AM
12
//-->